Financing essential HIV services: a new economic agenda.

Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study. BMJ Open (2016) 0.94

The increased effectiveness of HIV preventive intervention among men who have sex with men and of follow-up care for people living with HIV after 'task-shifting' to community-based organizations: a 'cash on service delivery' model in China. PLoS One (2014) 0.94

Challenges in HIV Vaccine Research for Treatment and Prevention. Front Immunol (2014) 0.93

The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020. PLoS Med (2015) 0.90

Assessing cost and technical efficiency of HIV prevention interventions in sub-Saharan Africa: the ORPHEA study design and methods. BMC Health Serv Res (2014) 0.83

Innovative financing for HIV response in sub-Saharan Africa. J Glob Health (2016) 0.77

Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission. AIDS (2016) 0.75

Towards cash transfer interventions for tuberculosis prevention, care and control: key operational challenges and research priorities. BMC Infect Dis (2016) 0.75

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Overcoming health-systems constraints to achieve the Millennium Development Goals. Lancet (2004) 15.43

Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89

Public financing of health in developing countries: a cross-national systematic analysis. Lancet (2010) 11.22

Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet (2009) 4.33

The global financial crisis has led to a slowdown in growth of funding to improve health in many developing countries. Health Aff (Millwood) (2011) 2.21

Improving responsiveness of health systems to non-communicable diseases. Lancet (2013) 2.06

Economic returns to investment in AIDS treatment in low and middle income countries. PLoS One (2011) 1.98

Financing the response to HIV in low-income and middle-income countries. J Acquir Immune Defic Syndr (2009) 1.78

Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31. Lancet (2010) 1.46

HIV spending as a share of total health expenditure: an analysis of regional variation in a multi-country study. PLoS One (2010) 1.23

Innovative financing for health: what is truly innovative? Lancet (2012) 1.19

How much can we gain from improved efficiency? An examination of performance of national HIV/AIDS programs and its determinants in low- and middle-income countries. BMC Health Serv Res (2012) 1.16

Addressing the structural drivers of HIV: a luxury or necessity for programmes? J Int AIDS Soc (2012) 1.11

The prospects of creating 'fiscal space' for the health sector. Health Policy Plan (2006) 1.08

Health and the post-2015 development agenda. Lancet (2013) 1.08

Paying girls to stay in school: a good return on HIV investment? Lancet (2012) 0.87

Financing intersectoral health promotion programmes: some reasons why collaborators are collaborating as indicated by cost-effectiveness analyses. Scand J Public Health (2011) 0.79

Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola. PLoS Med (2016) 1.68

Integrating cervical cancer with HIV healthcare services: A systematic review. PLoS One (2017) 0.75